A Propestive, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Even-Driven, Non-Inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 59-7939) With Adjusted-Dose

  • Ziada, Khaled (PI)
  • Steinhubl, Steven (Former PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/076/30/13